Winton Group’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-23,760
Closed -$646K 1528
2021
Q3
$646K Sell
23,760
-4,687
-16% -$116K 0.04% 728
2021
Q2
$486K Sell
28,447
-2,138
-7% -$40K 0.03% 936
2021
Q1
$639K Buy
30,585
+575
+2% +$13.3K 0.04% 737
2020
Q4
$687K Sell
30,010
-57,115
-66% -$1.09M 0.05% 619
2020
Q3
$1.42M Sell
87,125
-2,140
-2% -$38.8K 0.05% 667
2020
Q2
$1.21M Buy
89,265
+37,073
+71% +$431K 0.03% 885
2020
Q1
$618K Buy
52,192
+7,227
+16% +$160K 0.02% 969
2019
Q4
$1.12M Buy
44,965
+34,764
+341% +$704K 0.02% 1023
2019
Q3
$174K Buy
+10,201
New +$186K ﹤0.01% 1411
2018
Q3
Sell
-12,365
Closed -$463K 1178
2018
Q2
$463K Sell
12,365
-2,019
-14% -$79.3K 0.01% 659
2018
Q1
$565K Buy
+14,384
New +$525K 0.02% 716

Other funds holding XENT

Winton Group's XENT Position: Q4 2021 in Review

Winton Group sold out of Intersect ENT, Inc (XENT) in Q4 2021, closing a stake of 23,760 shares — an estimated $646K sold.

Winton Group first reported a position in XENT in Q1 2018 and held it in 11 quarters. The position peaked at $1.42M in Q3 2020. 121 funds tracked by Wall St. Rank hold XENT as of Q4 2021.

  • Winton Group reported no remaining Intersect ENT, Inc position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 23,760 Intersect ENT, Inc shares in Q4 2021, an estimated $646K.
  • Winton Group first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 11 quarters.
  • Winton Group's Intersect ENT, Inc position peaked at $1.42M in Q3 2020.
  • 121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.